Compare FMS & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMS | COO |
|---|---|---|
| Founded | 1996 | 1980 |
| Country | Germany | United States |
| Employees | 108165 | N/A |
| Industry | Misc Health and Biotechnology Services | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.2B |
| IPO Year | N/A | 1994 |
| Metric | FMS | COO |
|---|---|---|
| Price | $21.99 | $67.32 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $30.00 | ★ $90.18 |
| AVG Volume (30 Days) | 754.1K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $2,532,800,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | $3.83 | $5.18 |
| P/E Ratio | ★ $15.62 | $94.08 |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $20.02 | $58.89 |
| 52 Week High | $29.07 | $89.83 |
| Indicator | FMS | COO |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 66.11 |
| Support Level | $21.76 | $64.19 |
| Resistance Level | $24.02 | $70.01 |
| Average True Range (ATR) | 0.32 | 1.58 |
| MACD | 0.03 | 0.72 |
| Stochastic Oscillator | 70.52 | 94.80 |
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.